iPRI signs MOU with International Alliance of Patients’ Organizations (IAPO)
Lyon, 1 February 2017 – Today, the International Prevention Research Institute (iPRI), represented by its President, Professor Peter Boyle, concluded discussions and signed an important Memorandum of Understanding with the International Alliance of Patients’ Organizations (IAPO), represented by the Chair of the Board, Jolanta Bilińska.
The role of patients’ organisations is morphing rapidly from its initial lobbying focus to taking on a much more involved and proactive role from participating in clinical trial design and to advocacy in the design of healthcare organisation and delivery. All the activity of IAPO is focused on promoting patient-centric healthcare. IAPO achieves this by being the global voice for people who suffer from any disease, disability, illness, impairment or syndrome, and by being the focal point for patients’ organisations around the world.
IAPO is a unique global alliance committed to improving the lives of patients from all around the world. IAPO nurtures relationships with members, partners and all those involved in healthcare, and build dialogue with decision-makers around the world to promote patient-centric healthcare. There are currently 276 Member Organisations in IAPO, representing 71 countries and 51 disease areas.
iPRI will work with IAPO in strengthening its research portfolio and providing the evidence-based information necessary in the current environment. iPRI will also benefit from having access to the patient’s voice in planning and executing its own research in a wide variety of disease areas including cancer, diabetes and multiple sclerosis.